Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Morlet

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Ophthalmology|December 3, 2013
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMark C Gillies, Richard J Walton, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Ophthalmology|December 3, 2014
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMark C Gillies, Anna Campain, Richard Walton, et al.
The British Journal of Ophthalmology|September 25, 2014
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataDaniel Barthelmes, Richard Walton, Anna E Campain, et al.
The Medical Journal of Australia|June 15, 2022
The incidence of falls after first and second eye cataract surgery: a longitudinal cohort studyLisa Keay, Kam Chun Ho, Kris Rogers, et al.
Retina (Philadelphia, Pa.)|July 10, 2013
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! ProjectMark C Gillies, Richard Walton, Julines Liong, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Ophthalmology|December 3, 2013
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMark C Gillies, Richard J Walton, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Ophthalmology|December 3, 2014
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMark C Gillies, Anna Campain, Richard Walton, et al.
The British Journal of Ophthalmology|September 25, 2014
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataDaniel Barthelmes, Richard Walton, Anna E Campain, et al.
The Medical Journal of Australia|June 15, 2022
The incidence of falls after first and second eye cataract surgery: a longitudinal cohort studyLisa Keay, Kam Chun Ho, Kris Rogers, et al.
Retina (Philadelphia, Pa.)|July 10, 2013
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! ProjectMark C Gillies, Richard Walton, Julines Liong, et al.
Pageof 8